Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech ...

Samsung has laid down the gauntlet with a bold declaration that progress on developing a non-invasive continuous glucose ...

Transforming global health demands smart chemistry, addressing urgent health challenges through innovative, durable medical ...

CGMs can also be used with insulin pump therapy. A sensor-augmented pump (SAP) combines the technology of an insulin pump with a continuous glucose sensor, allowing users to monitor glucose and ...

Key Features of InsulinQ’s CGM Technology: Continuous monitoring to reduce the need for frequent ... CloseCurlyDoubleQuote; Advancing Glucose Monitoring Solutions The acquired CGM ...

Samsung Electronics is making significant progress in developing a non-invasive, optically-based continuous blood glucose ...

XR Immersive Tech (CSE:VRAI) has acquired continuous glucose monitoring (CGM) technology from InsulinQ ・By incorporating AI, ...

Innovative glucose monitoring leverages spore-forming bacteria in a self-powered platform, enhancing accuracy and reliability ...

Samsung Nears Breakthrough in Non-Invasive Glucose Monitoring Samsung is on the verge of revolutionizing wearable health ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its ...